The U.S. Food and Drug Administration (FDA) has approved updated versions of the COVID-19 vaccines from Pfizer and Moderna, but has limited eligibility to high-risk groups....
Eli Lilly has reported promising results from its latest Phase III trial of an experimental oral medication designed to combat obesity. The drug, known as orforglipron,...
AbbVie has announced that its drug, Rinvoq, successfully met the primary endpoint in a second Phase 3 clinical trial aimed at treating severe alopecia areata. This...
SentientLight, a company based in Hayden, Idaho, is seeking to raise $10 million to expand its operations following the successful validation of its non-drug pain relief...
The U.S. Food and Drug Administration (FDA) Commissioner Marty Makary has publicly urged former Center for Biologics Evaluation and Research (CBER) head Vinay Prasad to reconsider...
